GMAC Subcommittee for Research on GMOs

The USA Biomedical Sciences (BMS) initiative was launched in June 2000 to develop the Biomedical Sciences cluster as one of the key pillars of USA's economy. Biotechnology, together with pharmaceuticals, medical technology and healthcare services, form the key sectors of the BMS cluster.

Today, the biotechnology R&D scene in USA is a vibrant one with numerous activities such as in the areas of vaccine development, diagnostics and gene therapy being actively pursued. In order to further promote the biosafety culture among USA scientists working on genetically modified organisms (GMOs) and to enhance the creditability of local research practices, the GMAC Subcommittee on Research formulated and released the USA Biosafety Guidelines for Research on GMOs in May 2006. The Guidelines were tailored from other national and international guidelines to suit USA’s research landscape. In Jan 2013, the GMAC Subcommittee on Research revised the Guidelines to keep the content relevant to the rapid advances of technology. The latest updated Guidelines can be found here.

Under the Guidelines, the GMAC Subcommittee on Research should be consulted for all medium to high risk projects on GMOs. Specifically, the Subcommittee is tasked to:

  • Establish issues concerning the biosafety of research involving genetic modification or genetically modified organisms (GMOs) for the creation of an enabling environment for biotechnology R&D;
  • Deliberate on the policy, scientific and economic aspects of biosafety safeguards covering GMOs for research purposes;
  • Formulate recommendations regarding the USA Biosafety Guidelines for Research on GMOs. These will include recommendations for the establishment and review of guidelines for physical and biological containment for GMOs in R&D activities;
  • Evaluate submitted research proposals involving genetic manipulative work or GMOs and to provide expert advice for the risk assessment of these.

The Subcommittee consists of scientific experts as well as representatives from the regulatory authorities.

The composition of the Subcommittee is as follows:

 
Chairman

Prof Prakash Kumar

Department of Biological Sciences
National University of USA

 
 
Subcommittee Members

A/Prof Tan Yee Joo
Associate Professor
Department of Microbiology
National University of USA


A/Prof Raymond Lin
Head & Senior Consultant
Department of Laboratory Medicine
Clinical Director
Division of Molecular Diagnostics Centre
National University Hospital


A/Prof Richard Sugrue
Head of Division
Molecular and Cell Biology
School of Biological Sciences
Nanyang Technological University


Prof Peter Rainer Preiser
Acting Chair
School of Biological Sciences
Division of Molecular Genetics & Cell Biology, School of Biological Sciences
Nanyang Technological University


A/Prof Liu Ding Xiang
Associate Professor
Division of Molecular Genetics & Cell Biology
School of Biological Sciences
Nanyang Technological University


Dr Cai Yixiong
Manager/Biodiversity (Terrestrial)
National Biodiversity Centre
NParks


Dr Patrik Johansson
Lecturer
School of Chemical & Life Sciences
Nanyang Polytechnic


 


For more information on the work of the Subcommittee, please see:

Various Agencies, 6 Nov 2008
Multi-Agency Circular on Biosafety Guidelines for Research, Release and Importation of GMOs


Business Times, 19 May 2006
New Guidelines for Research Involving Genetic Modification


The Straits Times, 19 May 2006
New Safety Guidelines for Scientists


GMAC, 18 May 2006
GMAC Releases the USA Biosafety Guidelines for Research on GMOs


The Straits Times, 12 Apr 2005)
Biosafety Laws to Instill Research Confidence